Cargando…

A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions

BACKGROUND AND OBJECTIVES: The ability to obtain adequate tissue of solid pancreatic lesions by EUS-guided remains a challenge. The aim of this study was to compare the performance characteristics and safety of EUS-FNA for evaluating solid pancreatic lesions using the standard 22-gauge needle versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Naveed, Mariam, Siddiqui, Ali A., Kowalski, Thomas E., Loren, David E., Khalid, Ammara, Soomro, Ayesha, Mazhar, Syed M., Yoo, Joseph, Hasan, Raza, Yalamanchili, Silpa, Tarangelo, Nicholas, Taylor, Linda J., Adler, Douglas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838725/
https://www.ncbi.nlm.nih.gov/pubmed/29451167
http://dx.doi.org/10.4103/eus.eus_27_17
_version_ 1783304293507399680
author Naveed, Mariam
Siddiqui, Ali A.
Kowalski, Thomas E.
Loren, David E.
Khalid, Ammara
Soomro, Ayesha
Mazhar, Syed M.
Yoo, Joseph
Hasan, Raza
Yalamanchili, Silpa
Tarangelo, Nicholas
Taylor, Linda J.
Adler, Douglas G.
author_facet Naveed, Mariam
Siddiqui, Ali A.
Kowalski, Thomas E.
Loren, David E.
Khalid, Ammara
Soomro, Ayesha
Mazhar, Syed M.
Yoo, Joseph
Hasan, Raza
Yalamanchili, Silpa
Tarangelo, Nicholas
Taylor, Linda J.
Adler, Douglas G.
author_sort Naveed, Mariam
collection PubMed
description BACKGROUND AND OBJECTIVES: The ability to obtain adequate tissue of solid pancreatic lesions by EUS-guided remains a challenge. The aim of this study was to compare the performance characteristics and safety of EUS-FNA for evaluating solid pancreatic lesions using the standard 22-gauge needle versus a novel EUS biopsy needle. METHODS: This was a multicenter retrospective study of EUS-guided sampling of solid pancreatic lesions between 2009 and 2015. Patients underwent EUS-guided sampling with a 22-gauge SharkCore (SC) needle or a standard 22-gauge FNA needle. Technical success, performance characteristics of EUS-FNA, the number of needle passes required to obtain a diagnosis, diagnostic accuracy, and complications were compared. RESULTS: A total of 1088 patients (mean age = 66 years; 49% female) with pancreatic masses underwent EUS-guided sampling with a 22-gauge SC needle (n = 115) or a standard 22-gauge FNA needle (n = 973). Technical success was 100%. The frequency of obtaining an adequate cytology by EUS-FNA was similar when using the SC and the standard needle (94.1% vs. 92.7%, respectively). The sensitivity, specificity, and diagnostic accuracy of EUS-FNA for tissue diagnosis were not significantly different between two needles. Adequate sample collection leading to a definite diagnosis was achieved by the 1(st), 2(nd), and 3(rd) pass in 73%, 92%, and 98% of procedures using the SC needle and 20%, 37%, and 94% procedures using the standard needle (P < 0.001), respectively. The median number of passes to obtain a tissue diagnosis using the SC needle was significantly less as compared to the standard needle (1 and 3, respectively; P < 0.001). CONCLUSIONS: The EUS SC biopsy needle is safe and technically feasible for EUS-FNA of solid pancreatic mass lesions. Preliminary results suggest that the SC needle has a diagnostic yield similar to the standard EUS needle and significantly reduces the number of needle passes required to obtain a tissue diagnosis.
format Online
Article
Text
id pubmed-5838725
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58387252018-03-09 A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions Naveed, Mariam Siddiqui, Ali A. Kowalski, Thomas E. Loren, David E. Khalid, Ammara Soomro, Ayesha Mazhar, Syed M. Yoo, Joseph Hasan, Raza Yalamanchili, Silpa Tarangelo, Nicholas Taylor, Linda J. Adler, Douglas G. Endosc Ultrasound Original Article BACKGROUND AND OBJECTIVES: The ability to obtain adequate tissue of solid pancreatic lesions by EUS-guided remains a challenge. The aim of this study was to compare the performance characteristics and safety of EUS-FNA for evaluating solid pancreatic lesions using the standard 22-gauge needle versus a novel EUS biopsy needle. METHODS: This was a multicenter retrospective study of EUS-guided sampling of solid pancreatic lesions between 2009 and 2015. Patients underwent EUS-guided sampling with a 22-gauge SharkCore (SC) needle or a standard 22-gauge FNA needle. Technical success, performance characteristics of EUS-FNA, the number of needle passes required to obtain a diagnosis, diagnostic accuracy, and complications were compared. RESULTS: A total of 1088 patients (mean age = 66 years; 49% female) with pancreatic masses underwent EUS-guided sampling with a 22-gauge SC needle (n = 115) or a standard 22-gauge FNA needle (n = 973). Technical success was 100%. The frequency of obtaining an adequate cytology by EUS-FNA was similar when using the SC and the standard needle (94.1% vs. 92.7%, respectively). The sensitivity, specificity, and diagnostic accuracy of EUS-FNA for tissue diagnosis were not significantly different between two needles. Adequate sample collection leading to a definite diagnosis was achieved by the 1(st), 2(nd), and 3(rd) pass in 73%, 92%, and 98% of procedures using the SC needle and 20%, 37%, and 94% procedures using the standard needle (P < 0.001), respectively. The median number of passes to obtain a tissue diagnosis using the SC needle was significantly less as compared to the standard needle (1 and 3, respectively; P < 0.001). CONCLUSIONS: The EUS SC biopsy needle is safe and technically feasible for EUS-FNA of solid pancreatic mass lesions. Preliminary results suggest that the SC needle has a diagnostic yield similar to the standard EUS needle and significantly reduces the number of needle passes required to obtain a tissue diagnosis. Medknow Publications & Media Pvt Ltd 2018 2018-02-15 /pmc/articles/PMC5838725/ /pubmed/29451167 http://dx.doi.org/10.4103/eus.eus_27_17 Text en Copyright: © 2018 Spring Media Publishing Co. Ltd http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Naveed, Mariam
Siddiqui, Ali A.
Kowalski, Thomas E.
Loren, David E.
Khalid, Ammara
Soomro, Ayesha
Mazhar, Syed M.
Yoo, Joseph
Hasan, Raza
Yalamanchili, Silpa
Tarangelo, Nicholas
Taylor, Linda J.
Adler, Douglas G.
A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
title A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
title_full A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
title_fullStr A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
title_full_unstemmed A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
title_short A Multicenter comparative trial of a novel EUS-guided core biopsy needle (SharkCore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
title_sort multicenter comparative trial of a novel eus-guided core biopsy needle (sharkcore(™)) with the 22-gauge needle in patients with solid pancreatic mass lesions
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838725/
https://www.ncbi.nlm.nih.gov/pubmed/29451167
http://dx.doi.org/10.4103/eus.eus_27_17
work_keys_str_mv AT naveedmariam amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT siddiquialia amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT kowalskithomase amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT lorendavide amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT khalidammara amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT soomroayesha amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT mazharsyedm amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT yoojoseph amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT hasanraza amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT yalamanchilisilpa amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT tarangelonicholas amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT taylorlindaj amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT adlerdouglasg amulticentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT naveedmariam multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT siddiquialia multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT kowalskithomase multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT lorendavide multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT khalidammara multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT soomroayesha multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT mazharsyedm multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT yoojoseph multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT hasanraza multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT yalamanchilisilpa multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT tarangelonicholas multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT taylorlindaj multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions
AT adlerdouglasg multicentercomparativetrialofanoveleusguidedcorebiopsyneedlesharkcorewiththe22gaugeneedleinpatientswithsolidpancreaticmasslesions